Skip to content
10-Q

Quarterly Report

Rich Pharmaceuticals, Inc.

0001662252-17-000240

← back to feed
Filed
Dec 6, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2018 · Dec 4, 2017 350.14M sh
Operating Cash Flow Q1 2018 · Jun 30, 2017 −$175.97K
Operating Cash Flow Q1 2018 · Jun 30, 2016 −$132.48K
Short Term Debt Q1 2018 · Jun 30, 2017 $920K
Short Term Debt Q1 2018 · Mar 31, 2017 $920K
Cash And Equivalents Q1 2018 · Jun 30, 2017 $3.7K
Cash And Equivalents Q1 2018 · Mar 31, 2017 $40.9K
Stockholders Equity Q1 2018 · Jun 30, 2017 −$7.51M
Stockholders Equity Q1 2018 · Mar 31, 2017 −$5.33M
Current Liabilities Q1 2018 · Jun 30, 2017 $7.53M
Current Liabilities Q1 2018 · Mar 31, 2017 $5.38M
Total Liabilities Q1 2018 · Jun 30, 2017 $7.53M
Total Liabilities Q1 2018 · Mar 31, 2017 $5.38M
Current Assets Q1 2018 · Jun 30, 2017 $19K
Current Assets Q1 2018 · Mar 31, 2017 $50.9K
Total Assets Q1 2018 · Jun 30, 2017 $20.85K
Total Assets Q1 2018 · Mar 31, 2017 $53.03K
Rd Expense Q1 2018 · Jun 30, 2017 $147.57K
Net Income Q1 2018 · Jun 30, 2017 −$2.3M
Net Income Q1 2018 · Jun 30, 2016 −$178.36K
Operating Income Q1 2018 · Jun 30, 2017 −$471.48K
Operating Income Q1 2018 · Jun 30, 2016 −$215.48K